7 Hills Pharma Inc.

Houston, TX

UEI
CJJ6DE7APKY6
CAGE
78U51
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2450 Holcombe Blvd j, Houston, TX 77021, USA
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
7HP349, an integrin activator to treat patients with anti-PD-1 resistant solid tumors R44CA285207 National Cancer Institute (NIH) $3,996,800
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination R44AI176894 National Institute of Allergy and Infectious Diseases (NIH) $2,809,925
Integrin activator-adjuvanted DNA vaccine against trypanosoma cruzi infection R44AI172437 National Institute of Allergy and Infectious Diseases (NIH) $4,992,201
Integrin activation to augment sars-COV-2 vaccination R43AI162169 National Institute of Allergy and Infectious Diseases (NIH) $893,172
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors R44CA250646 National Cancer Institute (NIH) $4,031,182

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Purine Pharmaceuticals Inc. UEI K1FBL8EVSSK6 Gillette, NJ 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Aethlon Medical Inc. UEI MUNVGHPLRV56 — 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Soligenix, Inc. UEI GVD4XBVYD9J5 Princeton, NJ 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Larix Bioscience LLC UEI H3QRCCS8FK49 Sunnyvale, CA —
Oncosting, LLC UEI DJXQC89K4S79 Baltimore, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Here is a detailed, two paragraph summary on 7 Hills Pharma Inc.:

7 Hills Pharma Inc. is a for-profit biopharmaceutical company developing novel small molecule immunotherapies. Through federal grants, 7 Hills Pharma conducts research and development activities to advance its pipeline of investigational drugs designed to modulate the immune system and enhance the effectiveness of vaccines and other immunotherapies like immune checkpoint inhibitors.

As a prime recipient, 7 Hills Pharma has received over $8 million in federal grants from the National Institutes of Health to support preclinical and clinical development of its lead drug candidate, 7HP349. This includes conducting Phase I and Phase IB clinical trials evaluating 7HP349's safety and pharmacokinetics in healthy subjects and cancer patients, when combined with approved immunotherapies. Additional grants fund preclinical research on using 7HP349 as an adjuvant to boost immune responses to vaccines for influenza, Chagas disease, SARS-CoV-2, and tuberculosis. The company has also explored 7HP349's potential to treat leukocyte adhesion deficiencies. Major funding agencies include the National Cancer Institute and National Institute of Allergy and Infectious Diseases, under federal grant programs for cancer treatment research, allergy and infectious diseases research, and small business innovation research.

Quick answers

Is 7 Hills Pharma Inc. registered in SAM.gov?

Yes. 7 Hills Pharma Inc.'s SAM.gov registration is active through May 5, 2027.

What is 7 Hills Pharma Inc.'s most recent federal award?

7 Hills Pharma Inc.'s most recent federal grant award is 7HP349, an integrin activator to treat patients with anti-PD-1 resistant solid tumors (R44CA285207), from National Cancer Institute (NIH), on September 19, 2023.

On GovTribe

See 7 Hills Pharma Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login